Beauty Health Company (The) EBIT

The latest EBIT for SKIN is $-220M as of September 2021. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Beauty Health Company (The)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, SKIN currently prints $-220M for EBIT, while the sector average sits near $110B. That is roughly 100.2% below the sector mean. Large gaps often invite a closer look at Beauty Health Company (The)'s growth, margins, and balance sheet.

A EBIT figure of $-220M for SKIN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting SKIN's EBIT ($-220M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Beauty Health Company (The)'s EBIT against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.